Top compounds associated with response to IGFL2


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA lapatinib CTRPv2 pan-cancer AAC 0.11 0.002
mRNA Vorinostat gCSI pan-cancer AAC -0.15 0.003
mRNA 5-FU CTRPv2 pan-cancer AAC 0.098 0.003
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.1 0.005
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.095 0.008
mRNA VX-680 CTRPv2 pan-cancer AAC -0.3 0.009
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC 0.097 0.009
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.076 0.01
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC 0.085 0.01
Download CSV